Publicacións nas que colabora con Sabela Paradela de la Morena (57)

2024

  1. Prognostic significance of sentinel lymph node biopsy in elderly with cutaneous melanoma: systematic review and meta-analysis

    International Journal of Dermatology

2023

  1. A Life-Threatening Infection in Patients With Erythroderma: Psoas Abscess

    Actas Dermo-Sifiliograficas

2022

  1. Angioma-serpiginosum-like and hyperkeratotic lesions in a patient with Goltz syndrome

    Journal of Cutaneous Pathology, Vol. 49, Núm. 12, pp. 993-997

  2. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  3. Novel uses of laser therapy in Goltz syndrome

    Dermatologic Therapy, Vol. 35, Núm. 5

2020

  1. Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain

    Lupus, Vol. 29, Núm. 9, pp. 1021-1030

  2. Incidence rate and clinicopathological features of 62 atypical fibroxanthomas in a North-Western Spanish population

    Australasian Journal of Dermatology, Vol. 61, Núm. 1, pp. e22-e27

  3. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital

    Journal of Dermatological Treatment, Vol. 31, Núm. 7, pp. 698-701

2019

  1. Cutaneous Melanoma in the Elderly: Review of a Growing Problem

    Actas Dermo-Sifiliograficas

  2. Melanoma cutáneo en el anciano: revisión de un problema creciente

    Actas dermo-sifiliograficas, Vol. 110, Núm. 6, pp. 434-447

  3. Short-term morbidityassociated with ambulatory sentinel lymph node biopsy: A spanishtertiary care hospital based study and literature review

    Ambulatory Surgery, Vol. 25, Núm. 4, pp. 118-126

2018

  1. Cutaneous lupus erythematosus: quality of life and related factors in a cohort of 260 patients from A Coruña, Spain

    British Journal of Dermatology

2016

  1. Apremilast en dermatología

    Piel, Vol. 31, Núm. 3, pp. 206-215

  2. Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 5, pp. 1142-1148

2015

  1. Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting

    Journal of Dermatological Treatment, Vol. 26, Núm. 3, pp. 217-222

  2. Infliximab drug and antibody levels in patients with dermatological conditions

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 2, pp. 320-326

  3. Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

    Value in Health, Vol. 18, Núm. 8, pp. 1158-1161

2014

  1. Guías para el tratamiento de la psoriasis en placas moderada-grave con terapias biológicas

    Terapias biológicas para la psoriasis (Fundación do Complexo Hospitalario Universitario A Coruña), pp. 7

  2. Long-term response to etanercept monotherapy in moderate to severe psoriasis: Assessment in daily practice by the maintenance of low values of PASI and BSA

    Journal of Dermatological Treatment, Vol. 25, Núm. 1, pp. 54-56

  3. Paniculitis localizada en relación con tratamiento con acetato de glatirámero

    Piel, Vol. 29, Núm. 4, pp. 213-215